JP2025069304A5 - - Google Patents
Info
- Publication number
- JP2025069304A5 JP2025069304A5 JP2025015275A JP2025015275A JP2025069304A5 JP 2025069304 A5 JP2025069304 A5 JP 2025069304A5 JP 2025015275 A JP2025015275 A JP 2025015275A JP 2025015275 A JP2025015275 A JP 2025015275A JP 2025069304 A5 JP2025069304 A5 JP 2025069304A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- chain fatty
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762451192P | 2017-01-27 | 2017-01-27 | |
| US62/451,192 | 2017-01-27 | ||
| US201762510867P | 2017-05-25 | 2017-05-25 | |
| US201762510872P | 2017-05-25 | 2017-05-25 | |
| US62/510,872 | 2017-05-25 | ||
| US62/510,867 | 2017-05-25 | ||
| US201762530371P | 2017-07-10 | 2017-07-10 | |
| US62/530,371 | 2017-07-10 | ||
| US201762539572P | 2017-08-01 | 2017-08-01 | |
| US62/539,572 | 2017-08-01 | ||
| US201762588961P | 2017-11-21 | 2017-11-21 | |
| US62/588,961 | 2017-11-21 | ||
| JP2019562212A JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| PCT/US2018/015383 WO2018140687A1 (en) | 2017-01-27 | 2018-01-26 | Use of short chain fatty acids for the treatment and prevention of diseases and disorders |
| JP2022161035A JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022161035A Division JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025069304A JP2025069304A (ja) | 2025-04-30 |
| JP2025069304A5 true JP2025069304A5 (https=) | 2026-01-08 |
Family
ID=62978768
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562212A Active JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2022161035A Active JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2025015275A Pending JP2025069304A (ja) | 2017-01-27 | 2025-01-31 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562212A Active JP7161731B2 (ja) | 2017-01-27 | 2018-01-26 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
| JP2022161035A Active JP7688360B2 (ja) | 2017-01-27 | 2022-10-05 | 疾患及び障害の処置及び予防のための短鎖脂肪酸の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20220142978A1 (https=) |
| JP (3) | JP7161731B2 (https=) |
| KR (1) | KR102646764B1 (https=) |
| CN (1) | CN110475551A (https=) |
| WO (1) | WO2018140687A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10588871B1 (en) | 2019-06-28 | 2020-03-17 | Nexzol Pharma, Inc. | Transdermal formulation for the treatment of pain and/or inflammation |
| WO2021216548A1 (en) * | 2020-04-21 | 2021-10-28 | University Of Massachusetts | Methods and compositions for treatment of age-related macular degeneration |
| FR3111551B1 (fr) * | 2020-06-19 | 2022-08-26 | Oreal | Composition gélifiée comprenant un sel d’acide gras à chaîne courte |
| CN111632047A (zh) * | 2020-07-27 | 2020-09-08 | 上海市中医医院 | 木犀草素在预防和治疗子宫内膜异位症药物中的应用 |
| US20240009154A1 (en) * | 2020-08-04 | 2024-01-11 | Temple University-Of The Commonwealth System Of Higher Education | Methods and compositions for treating cytokine release syndrome |
| JP2023549522A (ja) * | 2020-11-12 | 2023-11-27 | テンプル・ユニバーシティ－オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | がん予防における短鎖脂肪酸の使用 |
| JP2024518421A (ja) * | 2021-05-07 | 2024-05-01 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | キメラ抗原受容体（ｃａｒ）ｔ細胞治療に関連する血清メタボロミクス |
| CN114767685B (zh) * | 2022-04-25 | 2023-10-20 | 北京大学第三医院（北京大学第三临床医学院） | 四氢叶酸在抑菌或者预防或治疗眼部疾病中的用途 |
| GB202208911D0 (en) * | 2022-06-17 | 2022-08-10 | Ravan Bio Limtied | Treatments |
| CN115068457A (zh) * | 2022-07-04 | 2022-09-20 | 南昌大学第一附属医院 | 短链脂肪酸在制备治疗急性胰腺炎药物中的应用 |
| WO2024100756A1 (ja) * | 2022-11-08 | 2024-05-16 | ミヤリサン製薬株式会社 | 子宮、卵管および卵巣における炎症の予防および／または治療剤 |
| FR3141616A1 (fr) * | 2022-11-09 | 2024-05-10 | Pll Therapeutics | Principes actifs et leur utilisation pour rétablir la perméabilité intestinale et/ou prévenir ou lutter contre des maladies multifactorielles |
| KR20250107214A (ko) * | 2022-11-10 | 2025-07-11 | 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 간질환 또는 간장애의 치료 또는 예방 방법 |
| WO2024151503A1 (en) * | 2023-01-11 | 2024-07-18 | Temple University- Of The Commonwealth System Of Higher Education | Treatment of skin disorders with short chain fatty acids |
| CN116687899B (zh) * | 2023-07-10 | 2025-03-21 | 河北医科大学第二医院 | 短链脂肪酸钠盐丁酸钠和丙酸钠组合用药在als治疗中的应用 |
| US12102611B2 (en) * | 2024-03-25 | 2024-10-01 | Olfactive Biosolutions, LLC | Compositions and methods for treating hypertension by modulating endocrine activity |
| US12226383B1 (en) | 2024-04-30 | 2025-02-18 | Velocity Life Sciences, LLC | Compositions containing short-chain fatty acid, methods of use, and methods of making thereof |
| CN120093748B (zh) * | 2025-03-26 | 2026-02-06 | 江汉大学 | 包含异戊酸和仑伐替尼的组合物在制备抗癌药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735967A (en) * | 1985-05-28 | 1988-04-05 | Neesby Torben E | Method for desensitizing the gastrointestinal tract from food allergies |
| JP2000072667A (ja) | 1998-08-25 | 2000-03-07 | Kurasuraa:Kk | 大腸炎治療用経口投与剤 |
| US8846039B2 (en) * | 2002-04-26 | 2014-09-30 | Asan Laboratories Company (Cayman), Limited | Method for ameliorating pruritus |
| US20080153908A1 (en) * | 2006-12-20 | 2008-06-26 | Jani Dharmendra M | Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition |
| CN101959429B (zh) * | 2008-01-08 | 2014-09-10 | 阿克塞利亚制药公司 | 抗微生物肽系统的激动剂 |
| US9339667B2 (en) * | 2009-02-18 | 2016-05-17 | Sea Qiq As | Mixture of inorganic compounds, preparations containing the mixture and use of the mixture |
| US8962686B2 (en) * | 2010-04-28 | 2015-02-24 | The Chinese University Of Hong Kong | Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| EP2389932A1 (en) * | 2010-05-28 | 2011-11-30 | Lunamed AG | Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts |
| MX2013001190A (es) * | 2010-07-29 | 2013-03-18 | Cosmo Technologies Ltd | Composiciones farmaceuticas y/o dieteticas con base en acidos grasos de cadena corta. |
| WO2012131069A1 (en) | 2011-03-31 | 2012-10-04 | Proponent Biotech Gmbh | Short chain fatty acids and their derivatives for use in treatment immunogenic disorders |
| WO2014022886A1 (en) * | 2012-08-08 | 2014-02-13 | Fischer Karen Jane | A method, use, and dietary supplement composition for at least treating an atopic or non-atopic disorder in a patient |
| WO2015006355A2 (en) * | 2013-07-09 | 2015-01-15 | Puretech Ventures, Llc | Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease |
| US10092541B2 (en) * | 2014-08-15 | 2018-10-09 | Celgene Corporation | Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast |
-
2018
- 2018-01-26 JP JP2019562212A patent/JP7161731B2/ja active Active
- 2018-01-26 KR KR1020197024459A patent/KR102646764B1/ko active Active
- 2018-01-26 WO PCT/US2018/015383 patent/WO2018140687A1/en not_active Ceased
- 2018-01-26 CN CN201880021752.2A patent/CN110475551A/zh active Pending
-
2022
- 2022-01-25 US US17/584,125 patent/US20220142978A1/en active Pending
- 2022-10-05 JP JP2022161035A patent/JP7688360B2/ja active Active
-
2024
- 2024-09-30 US US18/901,917 patent/US20250017883A1/en active Pending
- 2024-12-10 US US18/975,545 patent/US20250099410A1/en active Pending
-
2025
- 2025-01-31 JP JP2025015275A patent/JP2025069304A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025069304A5 (https=) | ||
| JP2022191257A5 (https=) | ||
| JP4415243B2 (ja) | 脂肪酸の治療効果の増強作用 | |
| ES2214729T3 (es) | Acido 9-cis-retinoico para enfermedades inmunes inducidas por celulas. | |
| EP0085579B1 (en) | Topical pharmaceutical compositions | |
| JP2024133474A5 (https=) | ||
| JP2022180461A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| TW200417368A (en) | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection | |
| JP2025092508A5 (https=) | ||
| JP2005509662A5 (https=) | ||
| US20060004076A1 (en) | Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation | |
| WO2002085327A2 (en) | Use of nsaids for prevention and treatment of cellular abnormalities of the female reproductive tract | |
| IL294736A (en) | Preparations including 15-hydroxy-eicosapentaenoic acid and methods of using them | |
| PH12021553056A1 (en) | Modified release formulations and uses thereof | |
| JP2005513014A5 (https=) | ||
| JP2024069223A5 (https=) | ||
| WO2024088153A1 (zh) | 托品酸及其衍生物在制备治疗银屑病药物中的用途 | |
| JP2017533956A (ja) | 筋肉痛を含む病態の治療のための組合せ | |
| RU2005122466A (ru) | Фармацевтические композиции, включающие комбинацию кальцитриола и клобетазола пропионат | |
| ECSP10010054A (es) | Composiciones farmacéuticas que comprenden la combinación de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa útiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas | |
| JPWO2019234240A5 (https=) | ||
| JP4890250B2 (ja) | 火傷した皮膚を治療するための方法及び組成物 | |
| JP2021521227A5 (https=) | ||
| JP2016518424A (ja) | ヘルペス処置のための薬剤と方法 |